Mr Seymour-Hamilton was originally struck off in 1994 after his Kent practice was found to be unhygienic and unsterile with poor record keeping.
However, he has always maintained that the reason his premises were unhygienic and unsterile was because they were closed.
As in previous applications, he said his reason for applying for restoration was to help him gain recognition for his alleged herbal and natural remedy discoveries and that he had no intention of going back into general practice.
As with previous applications, the Committee said that Mr Seymour-Hamilton has shown no real insight into the conduct underlying the original findings and nor has he shown insight into matters identified by previous restoration hearings.
The Committee also considered that Mr Seymour-Hamilton has been off the Register for some 31 years and would therefore need prolonged, intensive, formal retraining to ensure that he was now fit to practise, without which he might pose a risk to animal welfare.
Mr Seymour-Hamilton's case was not helped by the fact that he indicated that he had practised veterinary surgery while off the Register – including conducting two spay procedures in Calais, France, and treating two of his own dogs for cancer.
He also referred to having cultured faecal bacteria in a witness’ kitchen.
The Committee felt it was concerning that Mr Seymour-Hamilton thought these things were compatible with being on the Register and upholding the professional standards expected of a veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Mr Seymour-Hamilton still lacks an understanding as to why he has not been restored in the past.
"Apart from additional CPD, he has not set about effectively addressing any of his shortcomings.
"He relies passionately on his research, yet he does not support that research with any peer-reviewed publications, indeed all his attempts to gain recognition have been rebuffed.”
He added: “The Committee is firmly of the view that after such a prolonged period of failing to be reinstated as a veterinary surgeon, Mr Seymour-Hamilton has to face the reality that his continued applications, taking up time, resources and expense (which is ultimately borne by all those veterinary surgeons who are on the Register), are vexatious and ultimately unlikely to succeed.
“Whilst the College cannot prevent him from continuing to apply to be restored to the Register, Mr Seymour-Hamilton should by now realise that this is not a good use of the College’s finite resources.
"He is now 86 years old and has not practised for over thirty years and in fact has now been off the Register for longer than he was on it.
"This is now the twelfth time he has been found to be not fit to be restored to the Register.
"The Committee hopes Mr Seymour-Hamilton will now take time seriously to reflect and take into account the impact to all concerned of his continued applications, before deciding to submit any more.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The new resource is designed to help dog owners understand the risks of cancer, recognise the importance of early detection, and learn how HT Vista’s cancer detection device supports veterinary teams in screening suspicious masses.
It includes guidance on the early warning signs of cancer in dogs and explains how acting quickly can improve outcomes.
Dr Liron Levy-Hirsch, Veterinary Surgeon and Managing Director at HT Vista said: “We believe informed pet owners are key to driving earlier diagnosis.
"This new page is all about bridging the gap between innovative veterinary technology and the people it’s designed to support.
"By empowering pet owners with clear and trustworthy information, we hope to strengthen understanding of the diagnostic process, support clinical decision-making, and ultimately help more dogs receive timely treatment.”
www.ht-vet.com/petowners
In the webinar, which is sponsored by Horiba, Ian will present an update on new exotic parasite infections and distribution across the UK and Europe, and what this means for pets, livestock and the people that care for them.
“New Exotic Parasites – Worming Their Way In?” is suitable for vets, nurses, students and veterinary care assistants.
https://horiba.link/4h2.
Jonathan Hill, UK country manager at Dômes Pharma said: "Dômes Pharma is really excited to be extending our pet anxiety range to help vets manage cases in this complex area.
https://domespharma.co.uk/products/fluoxevet/
The merger brings together Improve International’s global reach and postgraduate qualification programmes with Central CPD’s practitioner-led Continuing Professional Development training and digital learning infrastructure.
Improve says the merger will better position the two companies to meet the growing and evolving needs of the profession.
However, the veterinary training marketplace has been hit recently by news that IVC Evidensia has opened two in-house training centres, one in Scotland and one in the Midlands, perhaps precipitating some consolidation, especially since IVC has announced plans to offer CPD to the wider profession later this year.
UK Pet Food says that with pet owners increasingly turning to their vets for nutrition guidance, this course is designed to equip veterinary teams with the knowledge and confidence to offer clear, evidence-based advice.
The course offers 20 hours of CPD comprised of on-demand modules and live Q&A sessions covering pet food formats, clinical nutrition, pet obesity, regulatory frameworks, sustainability, and client communication.
There'll be contributions from independent speakers and chairs from leading academics, veterinary nutritionists, and industry experts
Sarah Hormozi, Head of Science & Education at UK Pet Food, said: “This course is about helping veterinary professionals critically evaluate the science behind pet nutrition.
“We’ve worked with board-certified veterinary nutritionists, academics, industry experts, and veterinary associations to develop a resource that supports everyday clinical conversation - giving the veterinary community practical tools and confidence to talk about pet food and nutrition with clarity and credibility.”
There are early bird tickets for £90 if you book by 15th August 2025.
https://thewebinarvet.com/events/uk-pet-food-2025
https://www.ukpetfood.org
Photo: www.depositphotos.com
The BSAVA says there unique opportunities and risks to the use of antibiotics in rabbits.
For example, antibiotic combination therapy, which is discouraged in dogs and cats, can be safe and effective in this species.
Also, careful selection of appropriate antibiotics, in terms of active substance, dose and route of administration, is crucial when treating rabbits due to the risk of enterotoxaemia.The new guide gives advice on diagnosing bacterial infections, likely causal organisms and appropriate antibiotic and non-antibiotic management.
The guide covers dacryocystitis, ear disease, facial abscesses, enteritis, urinary tract disease, and upper and lower respiratory tract disease.John Chitty, one of the authors, said: “Choosing an antibiotic for rabbits is not simple.
"Their diseases do not necessarily mirror those of dogs and cats, and they do have gut sensitivities to certain antimicrobials.
"However, like dogs and cats, there are situations where antibiotics are not needed where we once thought they were.
"This is especially important in reducing antibiotic usage in rabbits and, of course, in reducing use of critically important antibiotics in them as well.
"We hope this guide will help practitioners to see when antibiosis is needed, what choices are available and how to sample and select the most appropriate drug if needed.”The new guide is free to all and can be accessed at bsavalibrary.com/protectme.
Krka says Arocenia provides fast, broad-spectrum anti-emetic efficacy with a 24-hour duration of action following a single daily dose.
It can be administered intravenously or subcutaneously and is supplied in 20 ml multi-dose vials, allowing up to 40 punctures per vial and a 60-day open vial shelf life.
Renzo Di Florio, Krka’s Technical Veterinary Adviser, commented “Vomiting is one of the most common presenting signs in small animal practice, and maropitant is a medication you’ll find on just about every vet’s dispensary shelf. With Arocenia, we’re adding a cost-effective formulation to the available options.”
https://www.krka.co.uk//products/our-products/animal-health/arocenia-10mgml-solution-for-injection
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
References
For example, a human generic paracetamol/codeine tablet costs approximately 3p at wholesaler prices.
By comparison, an almost identical licensed veterinary equivalent costs ten times as much.
The requirement for veterinary surgeons to prescribe expensive veterinary-licensed medications over cheaper unlicensed medications or drugs licensed for human use was first introduced though EU Directive 2001/82/EC in 2001, which the UK was legally required to implement in the form of the Veterinary Medicines Regulations 2013.
The main objectives of the EU directive were to safeguard public health by regulating medicines used in food-producing animals, to ensure the health and welfare of animals by requiring veterinary medicines to be authorised based on quality, safety and efficacy, to facilitate the free movement of medicines between member states and to encourage pharmaceutical innovation.
Whilst there is a strong rationale for the use of licensed medicines in food-producing animals, primarily to protect the public from medicine residues, the case for cats and dogs is weaker.
Furthermore, there is no evidence that legislators considered the increased cost to pet owners of implementing Directive 2001/82/EC, and the potential unintended consequences.
14 years later, this new research shows that the Veterinary Medicines Regulations 2013 may in fact harm companion animal welfare and stifle pharmaceutical innovation.
In terms of harm, the survey found that 38.8% of veterinary surgeons noted that owners are unable to afford the veterinary licensed drugs they are obliged to prescribe between 1-4 times per week.
Another 25.8% of vets said this happened very often, ie at least once a week.
Another 24% said it happened at least once a month.
From these figures, the authors calculated that 438,000 owners may be unable to afford vet licensed drugs over cheaper human-use generics.
In requiring vets to prescribe veterinary-licensed medications, there should obviously be a clear, measurable benefit to animal welfare.
For example, if it were possible to argue that the regulation has reduced the occurrence of adverse reactions to medication or inefficacy.
However, in the US, where no comparable regulation is in place and the same drugs are used, there is no evidence of this being the case, despite the very much larger population.
There is also evidence to suggest that the system may stifle, rather than promote the development of novel treatments, as pharmaceutical companies have prioritised the veterinary licensing of human use drugs over the development of new ones, because it costs them far less and carries less risk of failure.
Since the introduction of Directive 2001/82/EC, pharmaceutical companies have launched six novel veterinary medicines for companion animals in the EU, namely Frunevetmab, fluralaner, lokivetmab, bedinvetmab, lotilaner and pradofloxacin.
By contrast, over the same time period, there have been 13 human use drugs licensed for veterinary use, with no evidence to support the idea that they have become safer, better or more effective in animals than they were when the cheaper human-use variants were prescribed before the Directive was introduced.
David Mills MRCVS, lead author of the article, said: "It is incumbent on veterinary legislators and regulators to consider the impact of their legislation and regulation on the cost to the consumer and consequently on animal welfare.
"In this case, they need to consider whether the benefits of licensing are real and measurable, and that they outweigh any harm caused by impact of licensing on the cost of treatments.
"Whilst it is only right that pharmaceutical companies should be rewarded for developing novel treatments, removing the requirement for vets to prescribe licensed medication when a human generic exists, or even simply allowing discretionary use of unlicensed medication on the grounds of cost are all simple solutions that would better serve animal welfare, reduce costs to owners and promote research of new drugs."
PDF
Reference
The researcher say their analysis shows more needs to be done within the profession to acknowledge, raise awareness of and dismantle the systemic and often overlooked forms of racism that exist.
For the qualitative study, all BAME veterinary professionals and students in the UK were asked to complete an online questionnaire, containing open questions about their experiences.
The questionnaire was was distributed online, in veterinary schools, veterinary organisations and the media, with responses analysed using inductive and deductive approaches.
The findings identified three main themes regarding BAME people’s experiences in the sector.
The first was alienation and insecurity, ranging from blatant rejection, or being deliberately patronised, such as:
"In practicals in the vet school, I’ve noticed more and more times that students would rather work on other stations and not want to work on stations me and my friends (who are also from ethnic minority backgrounds) are working on, even when the other stations are full. This has happened on multiple occasions."
or
"On work experience, the vet I was shadowing at the time would ask me questions like, “Are you integrated into society yet?”, and “What do you eat?”. I am a British citizen who was born in the UK, and so were my parents, so I found this particularly confusing."
Through to more subtle forms of "othering":
"People assume that you aren't British and are different, whereas I would say since I was born and grew up in Britain that I identify as British. People ask me if I can speak another language, or like, do I eat my ethnic food all the time?
"An older couple once probed, “Where are you from?”, I said [name of UK city], they asked again, I said I grew up in [name of UK county], and they asked one more time and I said I have Caribbean heritage. I find this is a common form of racism amongst older people and often they’re not trying to be hurtful, but they’re curious and don't understand how it would make someone feel uncomfortable.
The second theme was homogenisation and inferiorisation, for example when BAME people are labelled, often incorrectly, according to perceived ethnicity:
"I've had lay colleagues refer to me as ‘the Chinese vet’ in front of clients and other colleagues rather than address me by my name – and it's weird because I grew up in Australia."
"Clients often asked to book in with the Singapore vet, but commonly referred to him as ‘the Chinese vet’ on the phone instead of his name, or if they forgot his name. I believe the nurses corrected these clients, but sometimes the clients would ‘jokingly’ comment that it's ‘the same thing’."
The final theme was the disappointment and futility felt by many of the participants, and the impact on their job satisfaction:
"Job satisfaction worsens when I learn that my colleagues (nurses or vets) are unaware of the impact of their words and do not understand what constitutes racism, e.g., use of the word ‘golliwog’, even when not used to describe a specific person. The judgement placed on someone due to their ethnicity creates an unpleasant atmosphere which impacts job satisfaction."
Dr Christine Thuranira-McKeever, Vice Principal (Equity, Diversity and Inclusion) and Director of Distance Learning at the RVC, said: “At the RVC, we are committed to fostering equality, diversity and inclusion (EDI) within the sector and have implemented several initiatives – aligned with our Strategic Plan in which EDI is a core component – to encourage participation from underrepresented groups.
"This includes the RVC For All campaign and Veterinary Gateway Programme to broaden access to veterinary education; the RVC's Equity, Diversity & Inclusion Committee and Race Equality Task Group to focus on addressing racial disparities and shaping policy; and Animal Aspirations, founded in 2019 by RVC students, to support individuals from minority backgrounds.
“However, there is more to be done, and the findings of this study emphasise a significant need for the veterinary profession to come together and do more to acknowledge and raise awareness of the systemic and often overlooked forms of racism, to challenge and dismantle them, and to empower those who are affected.”
The practice was officially opened by the TV presenter and newspaper columnist, Adrian Chiles, who faced a lot of criticism from the profession a couple of years ago when he wrote an article about increasing veterinary fees and upselling tactics.
Adrian said: “I have never received such a volume of correspondence to one of my newspaper columns.
"One of the people that wrote to me was Movement Director, Professor John Innes, and we had very useful subsequent discussions that made me realise I had unfairly blamed vets for the issues I had felt as a pet owner.”
The new centre is led by Mark Lowrie, Specialist veterinary neurologist, who is joined by orthopaedic surgeons, Kinley Smith and David Thomson and neurology residents, Callum Golding and Rebecca Clark.
https://www.movementvets.co.uk
The researchers say that previous research suggests that approximately 10% of diabetic cats are euthanised at the time of diagnosis, making it a significant cat welfare issue.
However, this figure was largely based on questionnaire-based research from several global locations.
This new study followed the survival of 1,053 cats with confirmed diabetes mellitus under UK primary-care practices in 2019, providing the most up-to-date baseline data on early death among diabetic cats in the UK, as well as examining risk factors for the development of diabetes among UK pet cats.
The study found:
Based on these findings, the researchers encourage veterinarians to more actively discuss diabetes mellitus risk with cat owners, particularly those with Burmilla and Burmese breeds, in the hope that raising awareness of the disease might improve outcomes through earlier diagnosis, and by taking actions that might prevent diabetes mellitus development in the first instance, such as preventing cats becoming obese.
Dr Oliver Waite, Senior Lecturer in Small Animal Medicine at Murdoch University, and primary author of the paper, said: “We hope that this new, large scale epidemiological study, investigating the second most common endocrine disease in cats, will help to highlight current as well as future areas to improve cat welfare.
"This is an exciting time for the management of diabetic cats but more work is still needed!”
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, and co-author of the paper, said: “This new VetCompass study shows the value of everyone working in primary care practice sharing their anonymised clinical data to get a better understanding of real-world animal health.
"Awareness of the scale of the diabetes mellitus issue revealed here can empower veterinary professionals to engage in more conversations with owners about diabetes mellitus prevention in predisposed cats.”
Mr Ng faced seven charges:
Mr Ng admitted some aspects of the charges against him, including that he had deleted two patient records and that this was dishonest and misleading.
The Committee then determined the facts of the rest of the charges after hearing evidence from witnesses and Mr Ng himself, as well as expert witnesses.
Having considered all the evidence, it determined which elements of the charges were proved, and which were not.
The Committee then considered whether the admitted and charges found proved amounted to serious professional misconduct.
In doing so it considered that the charges against Mr Ng fell into three broad categories – deficiencies in clinical care, deficiencies in record keeping, and dishonesty.
In respect of all three, it found the admitted and charges found proved amounted to serious professional misconduct.
In terms of aggravating factors, the Committee found that Mr Ng’s conduct had directly caused harm to animals and also created risk of further harm, and noted that there were three instances of dishonesty.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee noted that there were three instances of dishonest behaviour in relation to clinical records.
"The amendment of the clinical record in the labradoodle’s case was particularly serious.
"This alteration was made at a time when the respondent knew that the owner was dissatisfied with the treatment the dog had received and was complaining about the lack of therapeutic intervention.
"The alteration presented a false account of the owner’s attitude towards immediate therapeutic intervention.
"Conduct of this kind was liable to damage trust in the profession.”
In mitigation, the Committee took into account the sense of pressure Mr Ng felt following a financial dispute with his relative in respect of the veterinary practice, his long career as a veterinary surgeon and the high regard with which he was held by those who provided testimonials on his behalf.
The Committee acknowledged Mr Ng’s assertions that he now understood his failings and his expressions of remorse for the harm he had caused and that these indicated the beginnings of insight.
However, in respect of the clinical deficiencies, the Committee found that various aspects of Mr Ng’s approach to treating conditions such as diabetes and cherry eye were inadequate and out-of-date, and that there was little in his continuing professional development (CPD) record or his statements to suggest he had attempted to improve these deficiencies.
Ultimately, the Committee found that Mr Ng’s conduct was so serious that removal from the Register was the most appropriate sanction.
Paul Morris added: “The Committee has concluded that the respondent’s behaviour was fundamentally incompatible with being a veterinary surgeon.
"In view of the nature and gravity of the Committee’s findings in this case, removal from the Register is necessary to ensure the protection of animals and the maintenance of public confidence in the profession and the regulatory process.”
www.rcvs.org.uk/disciplinary
The College points to data gathered from its 2024 VN Vision workshops which showed that many nurses believe their skills and capabilities, and the scope of tasks that can be performed within the current legal framework, are not being fully used.
This new project aims to gather insights and empower nurses to play a more central role in the sector by promoting greater involvement in:
Session dates, times and locations are as follows:
Julie Dugmore RVN, RCVS Director of Veterinary Nursing, said: “Informed by conversations with professionals across the sector and a deep understanding of current practice, this new project recognises that achieving meaningful change requires a fundamental cultural shift.
"Clear guidance, structured support and open dialogue will be key in empowering veterinary teams to adapt to a new way of working.
“An additional crucial focus will be on enhancing public understanding of the Registered Veterinary Nurse (RVN) role, alongside support for developing stronger interprofessional and public-facing communication.”
Jill Macdonald RVN, VN Futures Lead, added: “These interactive sessions will play an important role in this new branch of VN Vision work, helping to define long term goals, identify the practical steps needed to achieve them, and determine how success will be measured and shared with the wider public.
“We were honoured to have so many fantastic nurses come together last year to help shape the future of the profession, and we’re looking forward to many more engaging conversations with vet team members this time around.
"This is more than just a conversation though – it’s a national effort to strengthen the RVN role through collaboration, clarity and confidence.”
The ‘A vision or a necessity: strengthening the role of veterinary nurses in team-based veterinary healthcare’ workshops are open to all practice team members, including, but not limited to, veterinary nurses, veterinary surgeons, practice support staff, directors, managers, and practice owners.
Workshops will be informal, informative and made up of small groups.
Supper will also be provided.
https://www.eventbrite.com/cc/vet-nursing-vision-events-3253639
https://www.rcvs.org.uk/news-and-views/publications/vn-vision-the-future-of-team-based-veterinary-healthcare/
The research was carried out by scientists from Wisdom Panel, a pet DNA testing company that is part of Mars Petcare’s Science & Diagnostics division.
The discovery was made by analysing clinical data from Banfield Pet Hospital paired with DNA data from Wisdom Panel.
The researcher say estimates suggest canine atopic dermatitis affects up to 10-30% of dogs, and that these findings could lead to more targeted solutions in the future.
In addition, identification of the SLAMF1 variant presents the opportunity for breeders to breed toward dogs with a lower risk of atopic dermatitis.
Jimmy Barr, DVM, DACVECC, Chief Medical Officer for Mars Petcare’s Science & Diagnostics division said: “This finding could have a real impact on dog health
"While atopy has long been suspected to have a genetic component, this is the first time the SLAMF1 gene has been convincingly linked to this debilitating skin condition.
"This knowledge will help identify dogs at risk and could lead to new therapies and more informed dog breeding practices.”
Wisdom Panel has developed a DNA test that will be offered in partnership with Canine Genetic Testing at the Department of Veterinary Medicine, University of Cambridge so breeders can make informed decisions to reduce the frequency of atopic dermatitis while maintaining genetic diversity.
https://www.cagt.co.uk/
Photo: https://depositphotos.com
Taking over the Presidency from Julian Hoad, David will continue to focus on the Programme of Change and the BSAVA’s new strategy, which includes some new products and services.
David qualified from the RVC in 1988 and has had a career largely in small animal practice, including a year in Canada.
He and his wife Rosie started the first feline-only practice in England and David is now an Advanced Practitioner in small animal dermatology.
He has postgraduate qualifications in small animal dermatology and medicine, becoming board certified in feline practice, and has an RCVS Fellowship on Feline Osteoarthritis.
David helped to set up the BSAVA West Midlands committee, before then becoming a BSAVA Council member and Chair of the Regions for three years before joining the Board and the presidential ladder.
David said: “It is an honour being BSAVA President for 2025-2026, but this next year will not be about me.
"It will be about the renewal of BSAVA, it will hear us shouting out with an ever-increasing voice about the most exciting innovations and I promise to do my very best.”
Julian Hoad will now move into the role of Senior Vice President, whilst Niall Connell begins his new role as Junior Vice President alongside Jo Megarity, who joins the Board as Honorary Treasurer.
The 2025 programme features 35 speakers from across the globe, delivering content across seven learning streams tailored to all levels of ECC experience—from new graduates to advanced practitioners.
Among the speakers this year are Elle Haskey, ECC specialist and RVN at the Royal Veterinary College, Helen Philp a Critical Care specialist at UC Davis in California, and Matt Rendle an RVN with experience in nursing care for many species from ants to elephants.
Simon Hagley, ECC Specialist and Clinical Director at Vets Now Manchester, who co-led the programme design with Racheal Marshall, RVN and Head of Clinic Nursing Standards, said: “We’ve built this year’s programme around delegate feedback, bringing back favourites like our ‘Controversies’ and ‘Joined Up Thinking’ sessions, while introducing new content that reflects the evolving landscape of ECC such as antimicrobial theory and practice,discussion panels on important consensus statements, and a stream looking at cutting edge medical developments and treatment modalities.
"Whether you’re just starting out or working at an advanced level, there’s something here for you.”
Racheal added: “Our goal is to create a dynamic, interactive learning environment. From practical workshops to non-clinical sessions on wellbeing and communication, we’re equipping delegates with the tools they need to thrive in high-pressure ECC settings.”
ECC Congress 2025 is open to all veterinary professionals, including vets, vet nurses, students, and graduates.
Animal Care Assistants and Veterinary Care Assistants can attend for the same rate as students.
Tickets range from £60+VAT for exhibition-only access to £575+VAT for full two-day attendance.
Gala Dinner tickets are sold separately.
vets-now.com/congress
The theme of Congress this year, at which veterinary nurses are welcome, is 'Adapt, Evolve, Succeed', considering how we can succeed both professionally and personally by embracing growth and change.
Billed as one of the most influential experts on change and human leadership in the world, Richard has advised governments and corporations such as Google and Microsoft
Early-bird prices start at £395 for the full event, with further group bundles and day tickets available.
www.spvs-congress.co.uk
richardgerver.com
Jessica Dawe, Deputy Head Nurse of Nine Mile Veterinary Hospital, won the individual award.
Her nomination read: "Every day, she comes in with a smile and puts in 100%, no matter the challenges faced the day before.
"Jess does not give herself the credit she deserves, as she is an amazing veterinary nurse, colleague, manager and friend to everyone.
"Her resilience, modesty, knowledge and clinical skills are admirable and we would be lost without her, and therefore, Jess is very much the diamond in our practice.”
The team award was won by the nursing team at ChesterGates Veterinary Specialists.
The runners up were Claire Mortimore from Caerphilly Veterinary Clinic, and the team at York Vets for Pets
BVNA President Lyndsay Hughes said: “The entries we have received have inspired and energised us, and we hope it’s been a real boost to all those who have been nominated too.
"It was incredibly difficult to judge the entries and shortlist our deserving winners and runners up, and we’d like to thank everyone to took the time to nominate their VN “diamonds”.
“Thank you to everyone who participated and played their part during this year's VNAM, which was especially important to us in 2025 taking place during BVNA’s 60th year.
"Your continued efforts are crucial to raise further awareness of the incredible work that veterinary nurses do, along with the significant impact they have on animal welfare, and in supporting veterinary teams and their clients.”
Stephen was recognised for his services to veterinary education and animals in science.
He served as RCVS President from 2017 to 2018 and has been actively involved in the work of the College for many years, serving a total of 19 years as a Council member, both as a vet school-appointee and an elected member, before retiring in 2024.
During his time on Council, he led the Legislative Reform Working Group which developed the Legislative Reform Proposals, as well as the Graduate Outcomes Project, out of which the Veterinary Graduate Development Programme was developed.
Kulin was recognised for his services to animal health and international trade.
RCVS President, Linda Belton MRCVS, said: “Huge congratulations to both Professor May and Dr Patel on this outstanding achievement.
"Thank you both for your extraordinary contributions to the veterinary profession during your careers, for which I would like to extend my appreciation on behalf of everyone at the RCVS.
“I would also like to extend congratulations to all those mentioned in the King’s Birthday Honours List for contributions to the veterinary world, animal health and welfare, and to the One Health concept more generally.
"We could not do the work we do without vital stakeholder collaboration, and it is fantastic to see outstanding individuals in the field being recognised for all they have contributed to our society.”
BraveBites contains protein, fish oil (rich in omega-3) and prebiotics.
The snack, which was developed with a veterinary nutritionist, has a soft texture and high palatability.
Camille, who worked for a year at Fitzpatrick Referrals, said: “In dogs undergoing cancer treatment, decreased appetite and weight loss are common.
"They negatively affect both prognosis and quality of life.
“Owners were constantly asking what they could still give their dog when food refusal started.”
Camille says that in a field test across 40 veterinary clinics in Belgium and the Netherlands, over 95% of oncology patients accepted the snack well, with a reported improvement in appetite and quality of life
BraveBites is available direct to vets, with educational material, client brochures, and quality-of-life monitoring tools.
http://www.bravebitespetfood.com
Zoetis says that the problem appears not to be an endemic wellbeing issue for which the answer might be to develop greater individual resilience, but rather it is a symptom of the working environment itself, fuelled by structural, cultural and economic factors.
This, the company argues, means that concentrating on individual resilience may be misguided, and a new approach is needed, one that addresses the environmental factors at play.
The white paper identifies three areas for change:
Firstly, a complete reimagining of the veterinary workplace with more flexible and sustainable working models.
This includes considering more flexible work rotas, using technology to ease workloads, and enhancing the supporting role of veterinary nurses.
Indeed the most important factor in improving workplace wellbeing and professional satisfaction, cited by 27% of vets, was to better train veterinary nurses to take on more responsibility.
Secondly, finding ways to adapt to meet growing and varied client needs.
The white paper recommends enhancing communication training, adopting technology for better client management, and offering more support for vets when managing emotionally challenging conversations with clients.
Finally, the paper calls for a rethink over how vets are selected for in the first place.
Currently, the profession draws from a pool of 96% white, 29% fee-paying, largely female people who are not representative of the market they serve.
Greater diversity in the profession, Zoetis says, delivers social benefits, strategic advantages and workplaces with broader perspectives and greater psychological safety.
Stephanie Armstrong, Regional President at Zoetis, said: “Addressing retention in the veterinary field requires looking beyond individual well-being to systemic factors.
"By fostering better work environments and providing support, we can help ensure that veterinarians continue to provide vital services to our communities.”
Zoetis is urging stakeholders across the veterinary and animal health sector to review the white paper’s insights and join a collective effort to implement solutions.
https://www2.zoetis.co.uk/about-zoetis/news-media/knowledge-hub/transforming-veterinary-practice-for-the-21st-century
Mr Kane was sentenced to two years’ imprisonment, suspended for 18 months in September 2024.
He was also disqualified from driving for two years until he had passed an extended driving test, and was ordered to undertake 200 hours of unpaid work within 12 months, and to pay a victim surcharge of £187.
It was alleged that the conviction rendered Mr Kane unfit to practise as a veterinary nurse.
From the outset, Mr Kane admitted the facts contained in the charge, but did not accept that this rendered him unfit to practise as a veterinary nurse.
After the criminal proceedings, Mr Kane wrote to express his deepest regret for his actions and the pain and guilt they had caused, stating that there was not a single day that had passed that he had not thought about the family that was affected by his actions, and the lifelong consequences that they now face.
He went on to express that he understood that as a member of a trusted profession, his conduct must reflect not only his clinical competence, but also his integrity and accountability.
He also noted that he had sought to recognise and address the consequences of his actions and that he is determined to make a positive contribution to society and to the profession.
The Committee found the charge proved on the basis of Mr Kane’s admission and the Certificate of Conviction.
The Committee found a number of factors relevant to the case:
The question for the Committee was whether Mr Kane’s conviction of causing serious injury by dangerous driving, when put into proper context, rendered him unfit to practise as a veterinary nurse.
This was not a conviction in any way linked to his practise and there was no suggestion that he represented any sort of a risk to animals in his care.
The Committee was not, therefore, concerned with any issues arising out of the need to protect animals, but rather with whether a finding of unfitness to practise was needed to uphold standards of conduct and behaviour in order to maintain public confidence in the profession.
Kathryn Peaty, Chair of the Committee and speaking on its behalf, said: “The Committee took into account the public interest which includes maintaining public confidence in the profession and the regulator and upholding proper standards in the profession.
"The public interest also includes allowing an otherwise competent veterinary nurse to continue in practice, where appropriate.
“Agreeing with the judge that this was indeed an exceptional case, the Committee did not consider that Mr Kane’s conduct was liable to have a seriously detrimental effect on the reputation of the profession and concluded that the public, in full knowledge of the circumstances of this particular case, would not expect a finding that the conviction renders him unfit to practise as a veterinary nurse.
"Rather, the public would recognise that whilst the consequences were appalling and tragic for the family involved, in terms of Mr Kane’s culpability this was a momentary piece of dangerous driving, categorised by the judge as a ‘mistake’ rather than anything more blameworthy.
“The Committee therefore concluded that Mr Kane’s conviction does not render him unfit to practise as a veterinary nurse.
"This is not to in any way detract from the catastrophic consequences for the family, but rather is to reflect the context, exceptional circumstances and level of culpability in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The updated content includes instructions on interpreting blood test results and dosing with Felimazole (thiamazole), which is now available as both a tablet and a honey-flavoured oral solution.
The new Felimazole Oral Solution formulation is presented in a syringe graduated in 0.25 mg increments to ensure accurate dosing.
Thomas Johnson, Dechra companion animal brand manager said: “Consistent management and accurate treatment is key to enabling cats with feline hyperthyroidism to lead long and healthy lives.”
Dechra’s Endocrine app already covers Addison’s disease and canine Cushing’s syndrome. The inclusion of feline hyperthyroidism content aims to provide a single resource for veterinarians managing endocrine disorders in companion animals.
Dechra’s Endocrine app is available at the Apple App Store or Google Play Store
https://www.dechra.co.uk/products#/search=Felimazole